🕵️ Oncotelic Therapeutics, Inc. ($OTLC)
SEC insider & ownership activity, last 12 months · CIK 908259 · every row links its SEC filing
Over the last 12 months insiders bought $38K with no open-market selling against it. Trieu Vuong bought $37K (Jun–Jul). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $38K (7 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Trieu Vuong | 6 | $37K | 0 | – | Jul 1, 2026 |
| Amit B. Shah | 1 | $1K | 0 | – | Jun 22, 2026 |
5%+ holders
No current 5%+ beneficial-ownership positions on file.
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jul 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 13, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jul 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 10, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 23, 2026 | filing ↗ |
| New financial obligation (2.03) | Jun 23, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 23, 2026 | filing ↗ |
| Material agreement (1.01) | May 1, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | May 1, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | May 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 1, 2026 | filing ↗ |
| Other events (8.01) | Apr 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 16, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 31, 2026 | filing ↗ |
| Other events (8.01) | Mar 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing ↗ |
| Other events (8.01) | Mar 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 24, 2026 | filing ↗ |
| Other events (8.01) | Mar 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 23, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 23, 2026 | filing ↗ |
| New financial obligation (2.03) | Jan 23, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jan 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 23, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 22, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 22, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 2, 2026 | filing ↗ |